Nizoral Anti-Dandruff Shampoo

Nizoral is a globally recognized medicated shampoo brand originally developed for the treatment of fungal infections of the skin and scalp. The brand's cornerstone is the active ingredient ketoconazole, which was first synthesized by Janssen Pharmaceutica in the late 1970s. Over decades, the brand has transitioned from a purely prescription-strength medication to a widely available over-the-counter solution for dandruff and seborrheic dermatitis.

While the brand originated in Belgium under the Johnson & Johnson umbrella, its ownership has become fragmented by region over the years. In the United States and Canada, the over-the-counter rights were acquired by Kramer Laboratories (now part of Arcadia Consumer Healthcare). Manufacturing for the North American market is primarily conducted in Canada. Internationally, in markets such as Europe, the Middle East, and Asia-Pacific, the brand was acquired from Johnson & Johnson by the German pharmaceutical company STADA Arzneimittel AG in 2018.

Today, Arcadia Consumer Healthcare manages the brand's growth in North America, focusing on expanding its therapeutic hair care line. Meanwhile, STADA continues to distribute and market Nizoral globally, maintaining its status as one of the most clinically-backed antifungal hair care brands in the world.